A5027120872- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Insurance, Mortality, Demography, Risk Management
- Health disparities and outcomes
- COVID-19 epidemiological studies
- Global Health Care Issues
- Respiratory viral infections research
- Medical and Agricultural Research Studies
- Healthcare Systems and Public Health
- Russia and Soviet political economy
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Data-Driven Disease Surveillance
- COVID-19 and healthcare impacts
University of the Basque Country
2024
European University at Saint Petersburg
2021-2022
National Research University Higher School of Economics
2019
BackgroundSince 2005, Russia has made substantial progress, experiencing an almost doubling of per-capita gross domestic product by purchasing power parity (GDP [PPP]) to US$24 800 and witnessing a 6-year increase in life expectancy, reaching 71·4 years 2015. Even greater gains GDP (PPP) were seen for Moscow, the Russian capital, $43 000 2015 with expectancy 75·5 years. We aimed investigate whether mortality levels now are consistent what would be expected given this new level...
Abstract Geographical variation in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) spread requires seroprevalence studies based on local tests, but robust validation is needed. We summarize an evaluation of antibody tests used a serological study SARS‐CoV‐2 Saint Petersburg, Russia. validated three different assays: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect immunoglobulin G (IgG), enzyme linked immunosorbent assay (ELISA) CoronaPass total antibodies...
Background The COVID-19 pandemic in Russia has already resulted 500,000 excess deaths, with more than 5.6 million cases registered officially by July 2021. Surveillance based on case reporting become the core monitoring method country and globally. However, population-based seroprevalence studies may provide an unbiased estimate of actual disease spread and, combination multiple surveillance tools, help to define course. This study summarises results from four consecutive serological surveys...
Background Despite the elaborate history of statistical reporting in USSR, Russia established modern population-based cancer registries (PBCR) only 1990s. The quality PBCRs data has not been thoroughly analyzed. This study aims at assessing comparability and validity statistics regions Northwestern Federal District (NWFD) Russia.Material methods Data from ten Russian regional covering ∼13 million (∼5 St. Petersburg) were processed line with IARC/IACR ENCR recommendations. We extracted...
В данной работе предпринимается попытка оценки непубликуемых производных показателей онкологической заболеваемости и смертности в населении РФ с использованием таблиц множественного выбытия – популяционной модели рака Д. Дюшен сложившихся условиях ограниченной доступности медико-демографических данных. Смоделированные таким образом показатели (средний возраст заболевания злокачественными новообразованиями (ЗНО), средняя ожидаемая продолжительность болезни, распространенность ЗНО средний...
Background The COVID-19 pandemic in Russia has already resulted 500,000 excess deaths, with more than 5.6 million cases registered officially by July 2021. Surveillance based on case reporting become the core monitoring method country and globally. However, population-based seroprevalence studies may provide an unbiased estimate of actual disease spread and, combination multiple surveillance tools, help to define course. This study summarises results from four consecutive serological surveys...
This paper aims to estimate Russian cancer incidence and mortality derivatives given limited access medical demographic data. We use the population model of proposed by J. Duchêne, which is a special case well-known multiple-decrement life table that makes it possible obtain otherwise inaccessible indicators, such as prevalence in population. Applying this publicly available data, we were able following indicators: average age at disease onset, duration disease, malignant cancer, death from...
Incidence-based multistate models of population health are commonly applied to calculate state expectancies, such as a healthy life expectancy (HLE), or unhealthy (UHE). These also allow the computation other summary indices, distributions lifespans. We aim show how model implies death distribution, giving joint information on years lived in good and poor health. propose three aggregate indices mortality inequality. double-accounting approach increment-decrement table methods intuitively...
Background An evident geographical variation in the SARS-CoV-2 spread requires seroprevalence studies based on local tests with robust validation against already available antibody and neutralization assays. This report summarizes evaluation of used representative population-based serological study Saint Petersburg, Russia. Methods We three different throughout study: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect IgG, Enzyme-linked immunosorbent assay (ELISA) CoronaPass...
Background: Since 2005, Russia has experienced an almost doubling of per capita GDP to $24,800 and increase in life expectancy (LE) six years reach 71*4 by 2015. In 2015, the Russian capital Moscow had LE equal $43,000 75*5 respectively. Given this progress are mortality levels seen consistent with what would be expected on basis Preston curve that expresses international relationship between national wealth?
Реально действующий популяционный раковый регистр дает возможность расчета системы показателей, характеризующих уровень онкологической заболеваемости и смертности населения на обслуживаемой регистром территории в некоторый период времени. Данные показатели по своим свойствам сходны с показателями таблиц мало зависят от возрастного состава населения, а также, некоторой мере, не предшествующие годы.
 К сожалению, объем анализа баз данных популяционных раковых регистров регионов России...